Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM
Table 5
Clinical characteristics of patients who did or did not receive antidiabetic treatment.
Antidiabetic treatment
value
No
Yes
Type of diabetes, n (%)
Type 1
1 (3.1)
31 (96.9)
0.005
Type 2
195 (24.9)
588 (74.1)
Time from onset of diabetes to DME, n (%)
Less than 5 years
27 (30.3)
62 (69.7)
<0.001
5–9 years
73 (40.8)
106 (59.2)
10–14 years
70 (29.2)
170 (70.8)
15–19 years
17 (9.9)
154 (90.1)
20 years +
9 (6.6)
127 (93.4)
Smoking status, n (%)
Smoking
6 (9.1)
60 (90.9)
<0.001
Used to smoke
12 (6.2)
183 (93.8)
Never smoked
178 (32.1)
376 (67.9)
Hypertension
Not present
151 (38.9)
237 (61.1)
<0.001
Present
45 (10.5)
382 (89.5)
Dyslipidemia
Not present
171 (32.3)
358 (67.7)
<0.001
Present
25 (8.7)
261 (91.3)
DME type: right eye, n (%)
Diffuse
121 (34.5)
230 (65.5)
<0.001
Focal
56 (19.3)
234 (80.7)
Mixed
10 (12.5)
70 (87.5)
DME type: left eye, n (%)
Diffuse
70 (24.8)
212 (75.2)
0.269
Focal
99 (29.1)
241 (70.9)
Mixed
16 (21.3)
59 (78.7)
CMT: right eye, n (%)
≤300 μm
47 (17.4)
222 (82.6)
0.001
>300 μm
147 (28.4)
371 (71.6)
CMT: left eye, n (%)
≤300 μm
42 (15.1)
237 (84.9)
<0.001
>300 μm
149 (29.9)
349 (70.1)
CMT: right eye; median (min–max)
376.5 (160–840)
342 (146–999)
0.002
CMT: left eye; median (min–max)
370 (201–780)
329 (148–999)
<0.001
CMT: central macular thickness; DME: diabetic macular edema. Mann-Whitney U, chi-square test, and Fisher’s exact test were used with Bonferroni correction.
